Summit Medical Group ends relationship with MD Anderson

Summit Medical Group has ended its relationship with MD Anderson, ROI-NJ has learned.

Summit CEO Dr. Jeffrey LeBenger confirmed the news late Thursday.

Summit had first announced the partnership with the Texas-based cancer brand in 2016, and jointly built a new cancer facility in Florham Park as an extension of MD Anderson’s brand at Cooper University hospital in Camden.

The facility opened Oct. 3, 2018.

“MD Anderson was a great partner, they helped us get our cancer center up and running,” LeBenger said.

“We had a different model. We have an ambulatory surgery model and they have a fully academic model within the hospital, so we felt that it would be better if we go our own ways because we have a different model of health care.”

The 130,000-square-foot cancer building, originally dual-branded, will remain under Summit’s management and brand, LeBenger said.

More from ROI-NJ on Summit Medical Group: